Figure 3.

Forest plots (individual and pooled effects with 95% CI) regarding the risk of selected neurotoxicity of fatigue (A, random-effects model), headache (B, fixed-effects model), dysgeusia (C, random-effects model), vertigo (D, fixed-effects model), paresthesia (E, fixed-effects model), anxiety or malaise (F, random-effects model) and peripheral neuropathy (G, random-effects model) associated with nivolumab versus controls.

Abbreviations: RR, risk ratio; CI, confidence interval; df, degree of freedom; M–H, Mantel–Haenszel.